Henry Meds Brings Hormone Replacement Therapies and Personalized Care to Patients Suffering with Menopause and Perimenopause Symptoms
Henry Meds to Provide Care Under the North American Menopause Society's (NAMS) Guidelines for Hormone Replacement Therapy
Average Age of Menopause Onset is 521, with Approximately 6 Thousand Americans Reaching Menopause Every Day2
DOVER, Del., April 29, 2025--(BUSINESS WIRE)--Telehealth company Henry Meds, known for its innovation in telehealth medicine and commitment to patient-centric care, announced today that it will now provide healthcare to patients suffering with symptoms associated with menopause and perimenopause.
"Our patients will benefit from our personalized care, expertise, experience, and the growing amounts of scientific data showing a clear benefit from hormone replacement therapy to provide relief from the daily and long-term impacts of menopause and perimenopause," said Dr. Steven Peacock, Chief Medical Officer, Henry Meds. "As leaders in the telehealth field, Henry Meds healthcare providers meet virtually with each patient to understand their symptoms and concerns, provide complimentary testing if appropriate and help determine the best therapeutic approach for each individual patient."
For many patients, the decrease in hormone levels caused by perimenopause and menopause lead to symptoms that impact their daily lives and can also lead to long-term health problems. Hormone replacement therapy (HRT) can offer significant relief from these symptoms.
"It's not just about the hot-flashes and daily symptoms when hormone production decreases in a patient's body," said Ana DeRosales MD, internal medicine and NAMS certified physician. "We know that living with a depletion of estrogen, progesterone and other hormones can lead to long-term health problems, from painful sex and osteoporosis to cardiovascular disease and joint pain. Working with a patient to find the best therapies for menopause and perimenopause through bioidentical therapies including progesterone, estrogen and other hormone replacement therapies is a well-studied and effective way to help patients find relief and long-term health benefits."
Henry Meds continues to revolutionize healthcare through its telehealth platform and commitment to patient-centric care. Henry Meds healthcare providers offer one-on-one care to patients across therapeutic areas including HRT, weight management, testosterone replacement therapy and erectile dysfunction.
Henry Meds continues its innovative research and development to further empower individuals to access quality healthcare solutions that are both convenient and accessible.
Patients can immediately set an appointment with a Henry Meds healthcare provider to discuss their symptoms and treatment goals by going to https://henrymeds.com/hrt/.
1https://www.nia.nih.gov/health/menopause/what-menopause#:~:text=Understand%20the%20menopausal%20transition,-The%20transition%20into&text=Most%20women%20begin%20the%20menopausal,52%20in%20the%20United%20States.2https://www.mayoclinichealthsystem.org/hometown-health/speaking-of-health/too-embarrassed-to-ask-part-3
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429559370/en/
Contacts
Jack Hirschfieldjack.hirschfield@henrymeds.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
7 minutes ago
- Newsweek
Thousands of Americans Told to Avoid Drive-Thru Lanes
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Thousands of Americans have been told to avoid drive-thru lanes amid concerns over high air pollution levels. The National Weather Service (NWS) has issued air quality alerts in Colorado, Texas, Nevada and Wyoming for Wednesday. The warnings mean ground-level ozone and particulate concentrations are forecast to reach dangerous levels. In some areas, the pollution comes from drifting wildfire smoke. Why It Matters The NWS warned that the general public as well as sensitive groups—children, seniors, and individuals with preexisting respiratory or heart conditions—might experience health effects linked to poor air quality in the affected regions. "Increasing likelihood of respiratory symptoms and breathing discomfort in active children and adults and people with lung disease, such as asthma," the NWS said. "Active children and adults, and people with lung disease, such as asthma, should reduce prolonged or heavy outdoor exertion." People wait in a queue at a drive-thru food distribution event in Austin, Texas, in 2021. People wait in a queue at a drive-thru food distribution event in Austin, Texas, in 2021. Mario Cantu/CSM/ZUMA Wire/Cal Sport Media/AP What To Know In Texas, an Ozone Action Day has been issued for the Houston, Galveston and Brazoria area, and the Dallas-Fort Worth metropolitan area on Wednesday. The Texas Commission on Environmental Quality (TCEQ) said that residents in these areas can reduce ozone pollution by "sharing a ride, walking, riding a bicycle, taking your lunch to work, avoiding drive-thru lanes, conserving energy and keeping your vehicle properly tuned." In Wyoming, an air quality alert for wildfire smoke has been issued until 1 p.m. on Wednesday for portions of the Bighorn Basin, Owl Creek Mountains, Bridger Mountains and Absaroka Mountains. Wildfire smoke across the Bighorn Basin, especially from the Red Canyon Fire, as well as fires in Idaho and Nevada, will continue to spread across the region on Wednesday. In Nevada, an Air Quality Action Day has been forecast for southwest Elko County, including Elko City, for elevated particulate matter. The air pollution is expected to be in the unhealthy for sensitive groups range. Meanwhile in Colorado, an Ozone Action Day Alert has been issued for the Front Range Urban Corridor until 4 p.m. on Wednesday. Hot and stagnant weather will allow ozone levels to reach levels that unhealthy for sensitive groups. "If possible, please help us reduce ozone pollution by limiting driving gas and diesel-powered vehicles until at least 4 p.m.," the Colorado Department of Public Health and Environment said. What People Are Saying The Wyoming Department of Environmental Quality said in a statement: "The Wyoming Department of Health recommends that the elderly, young children, and individuals with respiratory problems avoid excessive physical exertion and minimize outdoor activities during this time. "Wildfire smoke is made up of a variety of pollutants, including particulate matter and ozone, which can cause respiratory health effects. Although these people are most susceptible to health impacts, the Department of Health also advises that everyone should avoid prolonged exposure to poor air quality conditions." Jonathan Grigg, a professor of pediatric respiratory and environmental medicine at Queen Mary University of London, previously told Newsweek that there are "very clear links" between inhaling particles and earlier death from both respiratory and cardiovascular diseases. He added: "There are vulnerable groups and classically they are children because they've got an extra issue to do with their lungs developing, whereas our lungs are not developing as adults." What Happens Next The air quality warnings are currently set to remain in force until Wednesday afternoon in Wyoming and Colorado, and for the whole day in Texas and Nevada. Regular updates regarding air pollution levels are issued on the NWS website and on the Environmental Protection Agency's AirNow interactive map.
Newsweek
7 minutes ago
- Newsweek
'Beware' Mousse-Based Sunscreen, FDA Warns
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. While some sunscreens may look more appealing than others, the jury is now out on whether certain types do what they say on the bottle. The Food and Drug Administration (FDA) has issued a warning to "beware" sunscreen products that come in mousse form because they might not be effective. The federal agency has sent warning letters to five companies marketing sunscreen products in mousse-style—including brands Supergoop!, Vacation Inc., Kalani Sunwear, Botao Baby and Tizo Skin—and citing efficacy concerns, regulatory violations and packaging risks. Some companies are already pulling products from their U.S. sites, such as Kalani Sunwear. Woman applying sunscreen on man's face outdoors. Woman applying sunscreen on man's face outdoors. JordiThe FDA's letter to Supergoop!, for example, reads in part: "This letter is to advise you that on May 2nd, 2025 the U.S. Food and Drug Administration (FDA) reviewed your product labeling, including your website, where your 'Supergoop! PLAY SPF 50 BODY MOUSSE' drug product is available for purchase in the United States without a prescription." It said that based on their labeling—e.g. "Broad Spectrum Sunscreen SPF 50" and "Helps prevent sunburn..."—it is intended for use as an over-the-counter (OTC) sunscreen drug product, but no FDA-approved relevant application is in effect for this. On X, the FDA also warned: "Some mousse sunscreen products resemble whipped cream containers and may put consumers at risk if ingested." Beware of sunscreen products in mousse form because they might not be effective. The FDA issued five warning letters to companies marketing sunscreen products in mousse form: — FDA Drug Information (@FDA_Drug_Info) August 12, 2025 In light of this, Newsweek spoke to dermatologist professor Adam Friedman of the George Washington University about what the FDA warning means for Americans' sunscreen routines and how to choose safe and effective protection. "Sunscreens are OTC drugs, which distinguishes them from a moisturizer or a cosmeceutical. It means the regulation, the expectation in terms of efficacy, how well it works and safety is going to be different," Friedman explained. "But also what it relates to is not just the active ingredient, but the formulation—and that's where the whole mess comes in. "As of right now, under the 'monograph'—the umbrella of what is considered a sunscreen—oils, creams, lotions, gels, butters, pastes, ointments, powders, sprays and sticks fall under the category. Mousses and foams do not." Efficacy and safety are then a separate issue. "A mousse or a foam are aerated, and therefore how they interface with the skin when you rub them on may be very different from a cream or a spray or a stick," said Friedman. "We don't know if, based on that formulation, your UV filters—whether mineral or chemical—are going to behave the same way in the approved formulations. We can't guarantee that these mousse formulation sunscreens will actually work, let alone guarantee their safety." While Friedman said it is "concerning" some brands have not followed the correct process he hopes they were "trying to provide more options to hopefully ensure everyone is using a sun protection product". Smiling woman applying sunscreen on her face while looking in mirror in her bathroom. Smiling woman applying sunscreen on her face while looking in mirror in her bathroom. Ridofranz/Getty Images When deciding how to pick out the best sunscreen, Friedman advises going with the path of least risk. "That's going to be the sunscreens that do follow the monograph," he urged. "I tend to also say, go with the larger brand companies, because they have the size, wherewithal and resources to actually study their products. Not just ensure they meet FDA guidelines, but they'll do clinical studies to look at tolerability, cosmesis [preservation of appearance] and even the effect of these sunscreens on other things. "We use sunscreen not just to protect against skin cancer, but also accelerated skin aging and skin discoloration." Friedman said finding one that's right for you is still important. "Take these tried and true brands and do patch testing to see A) does your skin tolerate it and B) does it rub in well so you're not walking around with a white or purple cast. Samples from the dermatology office are so helpful." He recommends wearing at least an SPF 30 or higher each day. "I tend to say 50, not because there's such a huge delta between 30 and 50—and you will never 100 percent block UV radiation—but because these numbers are based on the FDA approach to measuring efficacy," Friedman said. While it's based on a set concentration of two milligrams of sunscreen per centimeter square of skin, most people don't put that much on. "The higher SPFs are good because it takes into account human error," he added. "With how much people are actually applying, a 70 ends up being a 40 and a 50 ends up being 30. "So in an ideal world: SPF, 30, maybe 50, broad spectrum, water resistant to 80 minutes. Then it's about what plays nice on your skin." Friedman himself wears sunscreen all year round, even in winter. "Every day to exposed areas. Do you brush your teeth every day? Sunscreen is the brushing the teeth of the skin. We brush our teeth to protect the integrity and health of our teeth. Applying sunscreen is the exact same thing." He also emphasized sunscreen is just one protection factor that should be used alongside wearing hats, sunglasses, the right clothing, seeking shade during peak hours and being fully aware. This includes knowing that windows won't block out UVA (while this will less likely cause burning, it can increase the risk of accelerated skin aging because it penetrates deeper). Supergoop! told Newsweek: "At Supergoop! we remain committed to innovation in sun care and the highest standards of product efficacy and safety. The recent communication from the FDA regarding our PLAY SPF 50 Body Mousse is focused on product labeling and has nothing to do with its safety, effectiveness, or formula. We are working closely with the FDA to resolve this matter as we continue to uphold the high standards our consumers expect from us." Vacation Inc told Newsweek: "At Vacation Sunscreen, we take regulatory compliance seriously and appreciate the opportunity to address the U.S. Food and Drug Administration's recent Warning Letter. We have full confidence in the safety, efficacy, and integrity of our product. We are committed to working collaboratively with the FDA to satisfactorily resolve this matter." Kalani Sunwear told Newsweek:"Kalani Sunwear acknowledges receipt of the FDA letter and has voluntarily paused sales in the U.S. while we review the administrative requirements. Importantly, the letter relates to regulatory classification only—not to the safety or efficacy of our SPF 50 mousse. Our formula is manufactured in Sweden, independently tested to EU standards, and uses advanced UV filters that are not yet approved in the U.S. (the FDA has not approved a new UV filter since 1999). We remain fully compliant with European regulations and stand by the quality and effectiveness of our product." Newsweek has also reached out to Botao Baby, Tizo Skin and the FDA for comment. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about sunscreen? Let us know via health@
Yahoo
29 minutes ago
- Yahoo
Adia Med Expands Into Wound Care, Targeting High-Demand $25 Billion Market and Unlocking New Growth Avenues
Winter Park, Florida--(Newsfile Corp. - August 20, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company at the forefront of regenerative medicine and personalized health solutions, today announced that its clinical division, Adia Med, is officially expanding into the high-demand field of advanced wound care. This strategic move enables the company to serve a wider patient base, meet a critical and growing healthcare need, and open a new stream of revenue that supports long-term shareholder value. Every year, an estimated 8.2 million Americans require medical treatment for chronic wounds, including diabetic foot ulcers, pressure sores, post-surgical wounds, and injuries resulting from poor circulation. These conditions are particularly prevalent among older adults and individuals with diabetes or vascular disease. Of those patients, approximately 1.6 million undergo skin graft procedures annually as part of their treatment and recovery process. As the population ages and chronic diseases become more widespread, the demand for advanced wound care is expected to rise sharply over the next decade. The wound care market is valued at $25.84 billion in 2025 and is projected to reach $38.39 billion annually by 2034, according to industry analyses (Precedence Research, 2024, link). This includes hospital-based interventions, outpatient procedures, home health services, and advanced therapies. Insurance providers are increasingly incentivizing high-quality, outpatient wound care as a cost-effective alternative to hospitalization, creating a significant opportunity for providers like Adia Med to lead with innovative, patient-centered approaches. By entering this sector, Adia Med is responding directly to market demand while establishing a scalable revenue stream that aligns with its broader clinical strategy. The company will begin offering wound care services at its flagship Winter Park, Florida clinic, with plans to expand based on patient volume, clinical partnerships, and insurance approval. Services will include personalized wound evaluations, evidence-based protocols, and regenerative support therapies designed to accelerate healing, reduce complications, and improve patient outcomes. "This expansion into wound care is both a mission-driven and market-smart decision," said Larry Powalisz, CEO of Adia Nutrition Inc. "We're addressing a real and growing problem that impacts millions of people, while also adding a new layer of value for our shareholders. Wound care represents a stable, high-reimbursement category with strong insurance support and we're stepping in with the tools, talent, and strategy to do it right." Adia Med is currently in-network with major insurance providers including UnitedHealthcare and Aetna, positioning the company to make wound care services accessible and affordable for a large number of patients from day one. This move also reinforces Adia Med's commitment to integrated, whole-person care by adding a new service line that complements its existing wellness and regenerative health offerings. As the company continues to grow, wound care will serve as both a meaningful healthcare solution and a durable revenue vertical contributing to Adia Med's mission of expanding access, driving innovation, and delivering sustainable returns for investors. For questions, inquiries, or additional information, please contact Larry Powalisz at ceo@ or by phone at 321-788-0850. Clinic owners and healthcare practitioners interested in licensing the Adia Med name or integrating Adia's regenerative therapies into their practice are encouraged to reach out directly. Strategic partnerships are welcomed as part of Adia's continued mission to expand access to advanced stem cell solutions. About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
